Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets closed

S&P Futures
5,886.75
-9.50(-0.16%)
Dow Futures
43,129.00
-48.00(-0.11%)
Nasdaq Futures
20,470.00
-49.50(-0.24%)
Russell 2000 Futures
2,250.10
-5.40(-0.24%)
Crude Oil
70.30
-0.26(-0.37%)
Gold
2,744.20
+5.30(+0.19%)

Revive Therapeutics Ltd. (RVV.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD

Follow

0.0100

+0.0050

(+100.00%)

At close: 02:58PM EDT

Currency in CAD

Valuation Measures⁴

Market Cap (intraday)	1.79M
Enterprise Value	804.35k
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	N/A
Price/Book (mrq)	0.18
Enterprise Value/Revenue	N/A
Enterprise Value/EBITDA	-2.39

Trading Information

Stock Price History

Beta (5Y Monthly)	-0.25
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	0.0400
52 Week Low ³	0.0050
50-Day Moving Average ³	0.0109
200-Day Moving Average ³	0.0209

Share Statistics

Avg Vol (3 month) ³	382.95k
Avg Vol (10 day) ³	249.61k
Shares Outstanding ⁵	358.45M
Implied Shares Outstanding ⁶	N/A
Float ⁸	411.61M
% Held by Insiders ¹	1.58%
% Held by Institutions ¹	0.01%
Shares Short (Sep 13, 2024) ⁴	16.4k
Short Ratio (Sep 13, 2024) ⁴	0.04
Short % of Float (Sep 13, 2024) ⁴	N/A
Short % of Shares Outstanding (Sep 13, 2024) ⁴	0.01%
Shares Short (prior month Aug 15, 2024) ⁴	9.83k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Jun 30, 2023
Most Recent Quarter (mrq)	Mar 31, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	0.00%

Management Effectiveness

Return on Assets (ttm)	-14.75%
Return on Equity (ttm)	-39.01%

Income Statement

Revenue (ttm)	N/A
Revenue Per Share (ttm)	N/A
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	-3.41M
Net Income Avi to Common (ttm)	-4.23M
Diluted EPS (ttm)	-0.0200
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	1.05M
Total Cash Per Share (mrq)	0
Total Debt (mrq)	61.51k
Total Debt/Equity (mrq)	0.63
Current Ratio (mrq)	0.40
Book Value Per Share (mrq)	0.02

Cash Flow Statement

Operating Cash Flow (ttm)	-3.58M
Levered Free Cash Flow (ttm)	-2.31M